Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Cash from Financing Activities (2020 - 2026)

Climb Bio filings provide 6 years of Cash from Financing Activities readings, the most recent being $5000.0 for Q1 2026.

  • Quarterly Cash from Financing Activities changed N/A to $5000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$16000.0 through Mar 2026, down 100.01% year-over-year, with the annual reading at -$21000.0 for FY2025, 100.02% down from the prior year.
  • Cash from Financing Activities hit $5000.0 in Q1 2026 for Climb Bio, up from -$21000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $128.4 million in Q2 2024 and bottomed at -$21000.0 in Q4 2025.
  • Average Cash from Financing Activities over 4 years is $13.2 million, with a median of $32500.0 recorded in 2023.
  • The largest annual shift saw Cash from Financing Activities soared 534908.33% in 2024 before it crashed 151.22% in 2025.
  • Climb Bio's Cash from Financing Activities stood at $288000.0 in 2023, then plummeted by 85.76% to $41000.0 in 2024, then crashed by 151.22% to -$21000.0 in 2025, then soared by 123.81% to $5000.0 in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Cash from Financing Activities are $5000.0 (Q1 2026), -$21000.0 (Q4 2025), and $41000.0 (Q4 2024).